| 0 |
DRUG INEFFECTIVE |
42 |
| 1 |
OFF LABEL USE |
42 |
| 2 |
BRADYCARDIA |
35 |
| 3 |
TOXICITY TO VARIOUS AGENTS |
32 |
| 4 |
BONE DENSITY DECREASED |
20 |
| 5 |
CALCIUM DEFICIENCY |
20 |
| 6 |
WEIGHT DECREASED |
20 |
| 7 |
DEATH |
16 |
| 8 |
HYPERKALAEMIA |
15 |
| 9 |
DRUG EFFECT INCOMPLETE |
14 |
| 10 |
ACUTE KIDNEY INJURY |
13 |
| 11 |
CARDIAC ARREST |
12 |
| 12 |
REBOUND EFFECT |
10 |
| 13 |
ATRIAL FIBRILLATION |
9 |
| 14 |
CARDIOACTIVE DRUG LEVEL INCREASED |
9 |
| 15 |
VOMITING |
9 |
| 16 |
CARDIAC FAILURE |
8 |
| 17 |
HYPOTENSION |
8 |
| 18 |
RENAL FAILURE |
8 |
| 19 |
VENTRICULAR FIBRILLATION |
8 |
| 20 |
COMPLETED SUICIDE |
6 |
| 21 |
GASTROINTESTINAL DISORDER |
6 |
| 22 |
MEDICATION ERROR |
6 |
| 23 |
MENTAL STATUS CHANGES |
6 |
| 24 |
VISUAL IMPAIRMENT |
6 |
| 25 |
ATRIOVENTRICULAR BLOCK SECOND DEGREE |
5 |
| 26 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
5 |
| 27 |
NAUSEA |
5 |
| 28 |
ATRIOVENTRICULAR BLOCK COMPLETE |
4 |
| 29 |
BLOOD POTASSIUM INCREASED |
4 |
| 30 |
CARDIO-RESPIRATORY ARREST |
4 |
| 31 |
DRUG EFFECT DECREASED |
4 |
| 32 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
4 |
| 33 |
NO ADVERSE EVENT |
4 |
| 34 |
THROMBOCYTOPENIA |
4 |
| 35 |
UNDERDOSE |
4 |
| 36 |
VENTRICULAR TACHYCARDIA |
4 |
| 37 |
ARRHYTHMIA |
3 |
| 38 |
ATRIOVENTRICULAR BLOCK |
3 |
| 39 |
ATRIOVENTRICULAR BLOCK FIRST DEGREE |
3 |
| 40 |
CONFUSIONAL STATE |
3 |
| 41 |
LABORATORY TEST INTERFERENCE |
3 |
| 42 |
PHARYNGEAL OEDEMA |
3 |
| 43 |
PNEUMONIA |
3 |
| 44 |
PNEUMONIA ASPIRATION |
3 |
| 45 |
PULSE ABSENT |
3 |
| 46 |
RASH |
3 |
| 47 |
RENAL FAILURE ACUTE |
3 |
| 48 |
RENAL IMPAIRMENT |
3 |
| 49 |
RESPIRATORY FAILURE |
3 |
| 50 |
SHOCK |
3 |
| 51 |
BLOOD CREATININE INCREASED |
2 |
| 52 |
BLOOD GLUCOSE INCREASED |
2 |
| 53 |
BRAIN INJURY |
2 |
| 54 |
CARDIAC FAILURE CONGESTIVE |
2 |
| 55 |
CARDIOGENIC SHOCK |
2 |
| 56 |
CHRONIC KIDNEY DISEASE |
2 |
| 57 |
CONTINUOUS HAEMODIAFILTRATION |
2 |
| 58 |
DRUG EFFECT DELAYED |
2 |
| 59 |
HAEMODIALYSIS |
2 |
| 60 |
INTENTIONAL OVERDOSE |
2 |
| 61 |
LEFT VENTRICULAR DYSFUNCTION |
2 |
| 62 |
LOSS OF CONSCIOUSNESS |
2 |
| 63 |
MALAISE |
2 |
| 64 |
OVERDOSE |
2 |
| 65 |
PRODUCT INEFFECTIVE FOR UNAPPROVED USE |
2 |
| 66 |
SINUS NODE DYSFUNCTION |
2 |
| 67 |
TACHYCARDIA |
2 |
| 68 |
UROSEPSIS |
2 |
| 69 |
ABDOMINAL PAIN |
1 |
| 70 |
AGITATION |
1 |
| 71 |
AGONAL RESPIRATION |
1 |
| 72 |
ANION GAP INCREASED |
1 |
| 73 |
ANTICOAGULATION DRUG LEVEL BELOW THERAPEUTIC |
1 |
| 74 |
ANURIA |
1 |
| 75 |
APNOEA |
1 |
| 76 |
ARTERIOSCLEROSIS CORONARY ARTERY |
1 |
| 77 |
ATRIAL FLUTTER |
1 |
| 78 |
ATRIAL TACHYCARDIA |
1 |
| 79 |
BLOOD ALBUMIN ABNORMAL |
1 |
| 80 |
BLOOD CHLORIDE DECREASED |
1 |
| 81 |
BLOOD CREATININE ABNORMAL |
1 |
| 82 |
BLOOD POTASSIUM DECREASED |
1 |
| 83 |
BLOOD PRESSURE DECREASED |
1 |
| 84 |
BLOOD PRESSURE DIASTOLIC DECREASED |
1 |
| 85 |
BLOOD PRESSURE SYSTOLIC INCREASED |
1 |
| 86 |
BLOOD SODIUM DECREASED |
1 |
| 87 |
BLOOD UREA ABNORMAL |
1 |
| 88 |
BLOOD UREA INCREASED |
1 |
| 89 |
BODY TEMPERATURE DECREASED |
1 |
| 90 |
BRADYARRHYTHMIA |
1 |
| 91 |
BRASH SYNDROME |
1 |
| 92 |
CARBON DIOXIDE DECREASED |
1 |
| 93 |
CARDIAC TAMPONADE |
1 |
| 94 |
CARDIOACTIVE DRUG LEVEL ABOVE THERAPEUTIC |
1 |
| 95 |
CARDIOACTIVE DRUG LEVEL DECREASED |
1 |
| 96 |
CATHETER SITE CELLULITIS |
1 |
| 97 |
CELLULITIS |
1 |
| 98 |
CHEST DISCOMFORT |
1 |
| 99 |
CHOREA |
1 |
| 100 |
CIRCULATORY COLLAPSE |
1 |
| 101 |
CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR |
1 |
| 102 |
CONDITION AGGRAVATED |
1 |
| 103 |
CORONARY ARTERY DISEASE |
1 |
| 104 |
DEHYDRATION |
1 |
| 105 |
DELIRIUM |
1 |
| 106 |
DEMENTIA |
1 |
| 107 |
DIARRHOEA |
1 |
| 108 |
DISABILITY |
1 |
| 109 |
DISORIENTATION |
1 |
| 110 |
DRUG ADMINISTRATION ERROR |
1 |
| 111 |
DRUG INTERACTION |
1 |
| 112 |
DRUG LEVEL FLUCTUATING |
1 |
| 113 |
DRUG LEVEL INCREASED |
1 |
| 114 |
DRUG MONITORING PROCEDURE NOT PERFORMED |
1 |
| 115 |
DYSPNOEA |
1 |
| 116 |
ELECTROCARDIOGRAM QRS COMPLEX ABNORMAL |
1 |
| 117 |
ELECTROCARDIOGRAM QT PROLONGED |
1 |
| 118 |
ELECTROCARDIOGRAM ST SEGMENT DEPRESSION |
1 |
| 119 |
EXTRASYSTOLES |
1 |
| 120 |
FALL |
1 |
| 121 |
HAEMODYNAMIC INSTABILITY |
1 |
| 122 |
HEART RATE DECREASED |
1 |
| 123 |
HEART RATE IRREGULAR |
1 |
| 124 |
HEPATIC INFARCTION |
1 |
| 125 |
HYPERHIDROSIS |
1 |
| 126 |
HYPOKALAEMIA |
1 |
| 127 |
HYPOPHAGIA |
1 |
| 128 |
HYPOTHERMIA |
1 |
| 129 |
ILEUS PARALYTIC |
1 |
| 130 |
INCORRECT PRODUCT STORAGE |
1 |
| 131 |
INTENTIONAL PRODUCT MISUSE |
1 |
| 132 |
INTENTIONAL PRODUCT USE ISSUE |
1 |
| 133 |
INTERCEPTED DRUG ADMINISTRATION ERROR |
1 |
| 134 |
INTERNATIONAL NORMALISED RATIO INCREASED |
1 |
| 135 |
LACTIC ACIDOSIS |
1 |
| 136 |
LEFT VENTRICULAR DILATATION |
1 |
| 137 |
LETHARGY |
1 |
| 138 |
LIVER FUNCTION TEST ABNORMAL |
1 |
| 139 |
LIVER FUNCTION TEST INCREASED |
1 |
| 140 |
LOWER GASTROINTESTINAL HAEMORRHAGE |
1 |
| 141 |
MALIGNANT HYPERTENSION |
1 |
| 142 |
MATERNAL EXPOSURE DURING PREGNANCY |
1 |
| 143 |
MENTAL DISORDER |
1 |
| 144 |
METABOLIC DISORDER |
1 |
| 145 |
MITRAL VALVE DISEASE |
1 |
| 146 |
MYDRIASIS |
1 |
| 147 |
MYOCARDIAL ISCHAEMIA |
1 |
| 148 |
NASOPHARYNGITIS |
1 |
| 149 |
NEONATAL RESPIRATORY DISTRESS SYNDROME |
1 |
| 150 |
NODAL RHYTHM |
1 |
| 151 |
PANCREATIC NECROSIS |
1 |
| 152 |
PERICARDIAL EFFUSION |
1 |
| 153 |
PERIPHERAL SWELLING |
1 |
| 154 |
PHARMACEUTICAL PRODUCT COMPLAINT |
1 |
| 155 |
PLEURAL EFFUSION |
1 |
| 156 |
POOR QUALITY DRUG ADMINISTERED |
1 |
| 157 |
PRESYNCOPE |
1 |
| 158 |
PRODUCT AVAILABILITY ISSUE |
1 |
| 159 |
PRODUCT PREPARATION ERROR |
1 |
| 160 |
PRODUCT PRESCRIBING ISSUE |
1 |
| 161 |
PRODUCT RECONSTITUTION QUALITY ISSUE |
1 |
| 162 |
PRODUCT USE IN UNAPPROVED INDICATION |
1 |
| 163 |
PULMONARY INFARCTION |
1 |
| 164 |
PULSELESS ELECTRICAL ACTIVITY |
1 |
| 165 |
RENAL INJURY |
1 |
| 166 |
RENAL REPLACEMENT THERAPY |
1 |
| 167 |
RESPIRATORY DISORDER |
1 |
| 168 |
RESPIRATORY DISTRESS |
1 |
| 169 |
RIB FRACTURE |
1 |
| 170 |
SEIZURE |
1 |
| 171 |
SINUS ARRHYTHMIA |
1 |
| 172 |
SINUS TACHYCARDIA |
1 |
| 173 |
SOMNOLENCE |
1 |
| 174 |
SYNCOPE |
1 |
| 175 |
TACHYARRHYTHMIA |
1 |
| 176 |
TACHYPNOEA |
1 |
| 177 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
1 |
| 178 |
THERAPEUTIC PRODUCT INEFFECTIVE FOR UNAPPROVED INDICATION |
1 |
| 179 |
THROMBOSIS |
1 |
| 180 |
TOXIC ENCEPHALOPATHY |
1 |
| 181 |
TROPONIN I INCREASED |
1 |
| 182 |
TROPONIN INCREASED |
1 |
| 183 |
TYPE IV HYPERSENSITIVITY REACTION |
1 |
| 184 |
UNRESPONSIVE TO STIMULI |
1 |
| 185 |
VENTRICULAR ARRHYTHMIA |
1 |
| 186 |
VENTRICULAR EXTRASYSTOLES |
1 |
| 187 |
VENTRICULAR FLUTTER |
1 |
| 188 |
VENTRICULAR HYPOKINESIA |
1 |
| 189 |
VERTIGO |
1 |
| 190 |
VISION BLURRED |
1 |
| 191 |
WITHDRAWAL SYNDROME |
1 |
| 192 |
WRIST FRACTURE |
1 |
| 193 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
1 |